TCIM
CBIO
TIAA CREF Investment Management’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $892K | Buy |
71,567
+6,856
| +11% | +$85.5K | ﹤0.01% | 2379 |
|
|
2018
Q4 | $613K | Sell |
64,711
-557
| -0.9% | -$5.28K | ﹤0.01% | 2482 |
|
|
2018
Q3 | $940K | Sell |
65,268
-9,415
| -13% | -$136K | ﹤0.01% | 2447 |
|
|
2018
Q2 | $1.21M | Buy |
+74,683
| New | +$1.21M | ﹤0.01% | 2416 |
|
|
2017
Q2 | – | Sell |
-30,934
| Closed | -$168K | – | 3148 |
|
|
2017
Q1 | $168K | Sell |
30,934
-409
| -1% | -$2.22K | ﹤0.01% | 3014 |
|
|
2016
Q4 | $191K | Hold |
31,343
| – | – | ﹤0.01% | 3048 |
|
|
2016
Q3 | $224 | Sell |
31,343
-1,441
| -4% | -$10 | ﹤0.01% | 3039 |
|
|
2016
Q2 | $238K | Buy |
+32,784
| New | +$238K | ﹤0.01% | 3070 |
|
|
2014
Q2 | – | Sell |
-32,343
| Closed | -$528K | – | 3135 |
|
|
2014
Q1 | $528K | Buy |
+32,343
| New | +$528K | ﹤0.01% | 2921 |
|